RWL - ETF AI Analysis
Top Page
Invesco S&P 500 Revenue ETF (RWL)
Rating:72Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and over the past few months, showing positive momentum.
Broad Sector Diversification
Holdings are spread across many sectors, including health care, financials, technology, consumer stocks, and energy, which helps reduce the impact of weakness in any single area.
Large Asset Base
The fund manages a substantial amount of assets, which can support liquidity and trading efficiency for investors.
Negative Factors
Higher Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of your returns go toward fees.
Heavy U.S. Concentration
Almost all of the ETF’s assets are invested in U.S. companies, offering little diversification across global markets.
Mixed Performance Among Top Holdings
While some major positions like Apple, UnitedHealth, CVS Health, and Exxon Mobil have performed strongly, others such as Walmart, Berkshire Hathaway, Cencora, and Microsoft have lagged, which can create uneven results.
RWL vs. SPDR S&P 500 ETF (SPY)
AUM9.98B
RegionNorth America
Expense Ratio0.39%
Beta0.73
IssuerInvesco
Inception DateFeb 19, 2008
Dividend Yield1.22%
Asset ClassEquity
Index TrackedS&P 500 Revenue-Weighted Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume198,355
30 Day Avg. Volume256,652
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
156.00Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering502
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RWL Summary
The Invesco S&P 500 Revenue ETF (RWL) is a fund that follows the S&P 500 Revenue-Weighted Index, which means it invests in many of the biggest U.S. companies but gives more weight to those that bring in higher sales. It holds well-known names like Amazon and Apple, along with firms from health care, finance, technology, and consumer sectors, so you get broad exposure to the U.S. stock market. Someone might invest in RWL for diversification and potential long-term growth from large, established companies. A key risk is that its value can rise and fall with the overall stock market.
How much will it cost me?The Invesco S&P 500 Revenue ETF (RWL) has an expense ratio of 0.39%, meaning you’ll pay $3.90 per year for every $1,000 invested. This is slightly higher than the average for passively managed ETFs because it uses a unique revenue-weighted strategy rather than traditional market-cap weighting, which requires more specialized management.
What would affect this ETF?The Invesco S&P 500 Revenue ETF (RWL) could benefit from strong consumer spending and technological advancements, as its top holdings include companies like Walmart, Amazon, and Apple, which are leaders in their sectors. However, rising interest rates or economic slowdowns could negatively impact sectors like Financials and Consumer Cyclical, which make up significant portions of the ETF's exposure. Additionally, regulatory changes in healthcare or technology could pose risks to major holdings such as UnitedHealth and Microsoft.
RWL Top 10 Holdings
RWL leans heavily on U.S. health care and tech names, with a revenue-first twist that puts companies like McKesson, Cencora, and UnitedHealth near the front of the pack. Microsoft has been a clear bright spot lately, giving the fund a lift alongside a steadily rising Exxon Mobil. On the other side, Walmart and CVS have been losing steam, acting as mild brakes on performance, while Amazon and Apple are more mixed. Overall, the ETF is diversified but clearly anchored in U.S. health care and Big Tech heavyweights.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Amazon | 3.94% | $394.13M | $2.77T | 12.55% | 71 Outperform | |
| Walmart | 3.17% | $317.00M | $850.10B | 3.54% | 78 Outperform | |
| Apple | 2.53% | $253.03M | $4.85T | 41.95% | 79 Outperform | |
| McKesson | 2.21% | $221.31M | $102.78B | 23.91% | 62 Neutral | |
| UnitedHealth | 2.05% | $205.80M | $340.27B | 7.54% | 72 Outperform | |
| Microsoft | 1.95% | $195.28M | $3.68T | -2.80% | 79 Outperform | |
| Berkshire Hathaway B | 1.95% | $194.81M | $982.67B | 3.37% | 66 Neutral | |
| CVS Health | 1.93% | $193.76M | $121.07B | 26.25% | 64 Neutral | |
| Cencora | 1.85% | $184.84M | $61.36B | 6.30% | 70 Neutral | |
| Exxon Mobil | 1.78% | $178.51M | $682.54B | 47.99% | 74 Outperform |
RWL Technical Analysis
Neutral
―
Price Trends
132.85
Negative
129.45
Positive
123.10
Positive
Market Momentum
-0.07
Positive
45.31
Neutral
21.78
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RWL, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 133.76, equal to the 50-day MA of 132.85, and equal to the 200-day MA of 123.10, indicating a neutral trend. The MACD of -0.07 indicates Positive momentum. The RSI at 45.31 is Neutral, neither overbought nor oversold. The STOCH value of 21.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for RWL.
RWL Peer Comparison
Comparison Results
Performance Comparison
RWL
Invesco S&P 500 Revenue ETF
132.55
24.05
22.17%
PRF
Invesco FTSE RAFI US 1000 ETF
―
―
―
TCAF
T. Rowe Price Capital Appreciation Equity ETF
―
―
―
JQUA
JPMorgan U.S. Quality Factor ETF
―
―
―
VONE
Vanguard Russell 1000 ETF
―
―
―
FELC
Fidelity Enhanced Large Cap Core ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents